Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2009-07-30
2011-10-18
Seaman, D M (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S137000
Reexamination Certificate
active
08039483
ABSTRACT:
Quinuclidine carbonate derivatives act as muscarinic receptor antagonists and are effective for the prevention and/or treatment of a broncho-obstructive or inflammatory diseases.
REFERENCES:
patent: 1 882 691 (2008-01-01), None
patent: 01/04118 (2001-01-01), None
patent: 02096855 (2002-12-01), None
patent: 03/053966 (2003-07-01), None
Amari Gabriele
Delcanale Maurizio
Chiesi Farmaceutici S.p.A.
Oblon, Spivak McClelland, Maier & Neustadt, L.L.P.
Rahmani Niloofar
Seaman D M
LandOfFree
Quinuclidine carbonate salts and medicinal composition thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quinuclidine carbonate salts and medicinal composition thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinuclidine carbonate salts and medicinal composition thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4273367